Skip to product information
1 of 1

MULTI SCIENCES

Mouse IL-1beta ELISA Kit Plate

Mouse IL-1beta ELISA Kit Plate

SKU:EK201B

Regular price Send Inquiry
Regular price Sale price Send Inquiry
Sale Sold out
View full details

Product Details

Mouse IL-1beta ELISA Kit Plate

Brand MultiSciences
CatNum 70-EK201B
Product Name Mouse IL-1beta ELISA Kit
Customs Name Mouse IL-1beta ELISA Kit
Application ELISA
Reactivity Mouse
Assay Type Sandwich ELISA
Suitable Sample Type serum, plasma, cell culture supernates
Format 96-well strip plate
Storage 4℃ (unopened) standard stored at -20℃, others stored at 4℃ (opened)
Shipping Condition 4℃
Sample Volume 20 μl
Sensitivity 4.28 pg/ml
Standard Curve Range 15.63 - 1000 pg/ml
Spike Recovery Range 83 % - 109 %
Mean Spike Recovery 0.97
CV of Intra plate 4.2 % - 8.4 %
CV of Inter plate 2.8 % - 5.6 %
Release Date 2016/8/20
Components 96-well polystyrene microplate coated with a monoclonal antibody against Mouse IL-1β
Mouse IL-1β Standard, lyophilized
Mouse IL-1β Detect Antibody
Standard Diluent
Streptavidin-HRP
Assay Buffer (10×)
Substrate (TMB)
Stop Solution
washing Buffer (20×)
Plate Covers
Describtion This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of mouse IL-1β. The Mouse IL-1β ELISA is for research use only. Not for diagnostic or therapeutic procedures.
Interleukin-1 (IL-1) is an extracellular peptide of 17 kDa that designates two proteins, IL-1α and IL-1β. IL-1β is produced by activated macrophages as a proprotein, which is proteolytically processed to its active form by caspase 1 (CASP1/ICE). This cytokine is an important mediator of the inflammatory response, and is involved in a variety of cellular activities, including cell proliferation, differentiation, and apoptosis.The interleukin-1 (IL-1) species represent an important family of biologically active mono nuclear cell-derived proteins which are involved in inflammatory reactions and in immune responses.
Increased production of IL-1β causes a number of different autoinflammatory syndromes, most notably the monogenic conditions referred to as CAPS, due to mutations in the inflammasome receptor NLRP3 which triggers processing of IL-1β.